Metastasis is a complex multi-step process that accounts for nearly 90% of cancer-related deaths. The ability to predict the participation of circulating tumor cells in metastasis and the location of secondary tumor sites has significant impacts on saving lives. Furthermore, in metastatic patients with no prior diagnosis records, a tool that can predict the primary cancer site based on the current metastatic state is of paramount importance for guiding therapies. Despite its vital importance, there exists no predictive method that could guide clinical decisions and therapies.
Firm adhesion of CTC with 10 attached platelets to the micro-vessel wall
We aim to develop a patient-specific imaging-based predictive framework to model the fluid dynamics within the patient’s circulatory system and to simulate the separation, transportation, and arrest of cancer cells. This framework will be developed to have the following capabilities: 1) to predict the most probable secondary-cancer sites to make a clinical diagnosis and staging more efficient and precise; 2) to predict the primary cancer site in metastatic patients with no prior records of primary cancer for targeted treatments.